emailContact Us    ASIP Members Access    Become a Supporter    News    Job Seekers/Employers    facebookGoogle+twitterinstagramlinkedinflickr

You can diagnosed buy viagra online was questionable though practicality.

Cheap no prescription buy Viagra online pharmacy


JMD Journal CME Program


Registration & General Information

 

Journal CME Homepage

Register Online

CME Statement

Download Registration Form


Download SAM Application Form


Frequently Asked Questions (FAQ)

CME Access for ASIP Journals


ASIP Member Journal Access Instructions


AMP Member Journal Access Instructions

 

Examinations

The following examination sheets are available for the convenience and reference of program participants. Participants must submit their examination answers ONLINE.
 

Exams - 2013 JMD CME Program in Molecular Diagnostics

 

Exam #1 (PDF) - JMD January 2013

Exam #2 (PDF) - JMD March 2013

Exam #3 (PDF) - JMD May 2013

Exam #4 (PDF) - JMD July 2013

Exam #5 (PDF) - JMD Sept 2013

Exam #6 (PDF) - JMD Nov 2013

 

Direct all Inquiries to:
ASIP CME Administrator
9650 Rockville Pike, Suite E-133
Bethesda, MD 20814 (USA)
Tel: 301-634-7440
Fax: 301-634-7990
Email: JournalCME@asip.org

Lisa McFadden

ASIP Educational Services Manager

Journal CME Program - JMD 2013 CME Program in Molecular Diagnostics

Mark E. Sobel, MD, PhD - Director of Journal CME Programs

JMD The JMD 2013 CME Program in Molecular Diagnostics is an annual program consisting of a series of 48 questions based on selected articles in the January - November 2013 issues (Volume 15, Numbers 1-6) of The Journal of Molecular Diagnostics (JMD). Bimonthly exams, consisting of 8 questions based on selected articles appearing in each bimonthly issue of the Journal, will be available online on the Journal website for registered participants.

To receive CME credit for this journal-based CME activity, participants must achieve a score of at least 75% on each

bimonthly exam and complete a Post-Test Evaluation. All exams must be completed by December 31, 2013 to receive CME credit. Participants will earn 8 AMA PRA Category 1 Credit(s)™ for successful completion of each exam.

Registration
Download the JMD 2013 CME Program in Molecular Diagnostics Registration Form (PDF) or register online. The JMD 2013 Journal CME exams can only be accessed with a paid subscription to the CME program. Participants may subscribe online via the AMP or ASIP websites or may mail or fax a completed Journal CME Registration Form along with the appropriate registration fee to the ASIP Education Office prior to gaining access.

Registration forms are also available from the ASIP Education Office, 9650 Rockville Pike, Bethesda, MD, 20814-3993, Tel: 301-634-7130; email journalcme@asip.org. After the Journal CME Registration has been processed, the ASIP Education Office will send CME subscribers information about how to access the CME exams.

2013 Subscription Rates (January - November 2013):

AMP/ASIP Member Rate - $150.00
Non-Member Rate - $225.00

Deadline
The deadline for receipt of the JMD 2013 CME Program in Molecular Diagnostics Subscription Form and online submission of answers and Evaluation Form is December 31, 2013.

Continuing Medical Education (CME)

This activity (“JMD 2013 CME Program in Molecular Diagnostics”) has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this journal-based CME activity (“JMD 2013 CME Program in Molecular Diagnostics”) for a maximum of 48 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The JMD 2013 CME Program in Molecular Diagnostics is an annual program consisting of a series of at least 48 questions based on selected articles in the 2013 issues (Volume 15) of The Journal of Molecular Diagnostics (JMD). Bimonthly exams, consisting of at least 8 questions that are based on selected articles appearing in each issue of the Journal, will be available online on the Journal website for registered participants.

To receive CME credit for this journal-based CME activity, participants must achieve a score of at least 75% on each bimonthly exam and complete a Post-Test Evaluation. All exams must be completed by December 31, 2013 to receive CME credit. Participants will earn 8 AMA PRA Category 1 Credit(s)™ for the successful completion of each bimonthly exam.

For more information regarding the CME Disclosure Policy and educational objectives, or to subscribe to the JMD 2013 CME Program in Molecular Diagnostics, please contact the ASIP Education Office by phone at (301) 634-7440; email (journalcme@asip.org), or mail your inquiry to 9650 Rockville Pike, Suite E-133, Bethesda, MD 20814.

SAM Credit

The JMD 2013 CME Program in Molecular Diagnostics is approved by the American Board of Pathology for up to 48 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. After successfully completing the bimonthly CME exams as described above, participants may separately apply for SAM credit by completing the SAM application found on the ASIP website (www.asip.org/CME/documents/ASIP2013JMDSAMApplication.pdf). All SAM applications must be received in our office by December 31, 2013 for participants to receive SAM credit.

 

For more information regarding SAM credits, please contact the ASIP Education Office by phone at (301) 634-7440; email (journalcme@asip.org), or mail your inquiry to 9650 Rockville Pike, Suite E-133, Bethesda, MD 20814.

Meeting Objective/Target Audience
The objective of the JMD 2013 CME Program in Molecular Diagnostics is to increase basic and applied pathology knowledge, focusing on the molecular pathogenesis, diagnosis, prognosis, and the treatment of disease. The JMD 2013 CME Program in Molecular Diagnostics is designed to meet the participants’ education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants’ lifelong learning towards a goal of promoting patient safety and improving patient care and is specifically targeted to trainees, clinicians and researchers investigating mechanisms of disease who wish to advance their knowledge of the cellular and molecular biology of disease.

Educational Objectives

Upon completion of the JMD 2013 CME Program in Molecular Diagnostics, participants should be able to:

  • discuss the research underway and/or current molecular approaches to the diagnosis and prognosis of inherited diseases and syndromes, pharmacogenetics, cytogenetics, DNA identity tests, and hematopathology, solid and soft tissue tumors; infectious diseases; and acquired diseases spanning systems biology.
  • demonstrate a gained level of knowledge of the molecular methods and techniques being used by researchers and practitioners.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest:

In order to ensure balance, independence, objectivity and scientific rigor in all its educational activities, and in accordance with ACCME Standards, the ASCP requires that all individuals in a position to influence and/or control the content of ASCP CME activities disclose to the ASCP and subsequently to learners whether they do or do not have any relevant financial relationships with proprietary entities producing health care goods or services that are discussed in CME activities.

Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and thus input is used for subsequent CME planning decisions. The primary purpose of this journal-based CME activity is educational and the comments, opinions, and/or recommendations expressed by the faculty or authors are their own and not those of ASCP or ASIP.

 

The planning committee members and staff of this journal-based CME activity have no relevant financial relationships with commercial interest to disclose. Relevant financial relationships of the authors of selected articles in this journal-based CME activity will be disclosed in a footnote to the published article and in each examination.